Clinical Trial Update: Probiotics in PBC Patients of Poor Response to UDCA [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating probiotics in patients with primary biliary cholangitis who respond poorly to UDCA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis

Snippet

Sponsor: Sun Yat-sen University | Conditions: Primary Biliary Cholangitis (PBC) | Phase 2 | Status: UNKNOWN